Albendazole

Active ingredient description

Αlbendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Albendazole
P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Medicines

Albendazole is the active ingredient of these drugs:

Drug
Countries

Ecuador

Brazil

Singapore

Ecuador

Brazil

Estonia United States

Ecuador

Singapore

Estonia Lithuania

Ecuador

Ecuador

South Africa

Ecuador

Australia Austria Estonia France Lithuania

Ecuador

Ecuador

Ecuador

Ecuador

Lithuania

Brazil

Brazil

Tunisia

South Africa

South Africa

Brazil

Ecuador

Ecuador

Ecuador

Ecuador

South Africa

Tunisia

Tunisia

Australia Ecuador France Poland Singapore

Cyprus

Brazil

Albendazole is also found within below combination drugs:

ASCARAMEB , PARASI-KIT , PARASIPACK , PAZIDOL 1-2 , PROTHELMINT

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 265.331 g/mol

External identifiers

CAS Substance: 54965-21-8
DrugBank Drug: DB00518
KEGG Drug: D00134
RxNorm Ingredient: 430
SNOMED-CT Concept: 387558006
Albendazole (substance)
UNII Identifier: F4216019LN
ALBENDAZOLE